Evaluación de la erupción maculopapular

Referencias

Artículos principales

Cherry JD. Parvovirus infections in children and adults. Adv Pediatr. 1999;46:245-69. Resumen

Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32(5):391-408. Resumen

Artículos de referencia

1. Resuscitation Council UK. Emergency treatment of anaphylactic reactions: Guidelines for healthcare providers. May 2021 [internet publication].Texto completo

2. Lott C, Truhlář A, Alfonzo A, et al. European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances. Resuscitation. 2021 Apr;161:152-219.Texto completo  Resumen

3. Ijaz N, McMullen E, Singh M. Cutaneous drug rashes. Br J Hosp Med (Lond). 2015 Nov;76(11):C166-9. Resumen

4. Modi A, Desai M, Shah S, et al. Analysis of cutaneous adverse drug reactions reported at the Regional ADR Monitoring Center. Indian J Dermatol. 2019 May-Jun;64(3):250.Texto completo  Resumen

5. Deng Q, Fang X, Zeng Q, et al. Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis. An Bras Dermatol. 2017 May-Jun;92(3):345-9.Texto completo  Resumen

6. Valeyrie-Allanore L, Sassolas B, Roujeau JC. Drug-induced skin, nail and hair disorders. Drug Saf. 2007;30(11):1011-30. Resumen

7. National Institute for Health and Care Excellence. Drug allergy: diagnosis and management. September 2014 [internet publication].Texto completo

8. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001 Jun;137(6):765-70. Resumen

9. Böhm R, Proksch E, Schwarz T, et al. Drug hypersensitivity. Dtsch Arztebl Int. 2018 Jul 23;115(29-30):501-12.Texto completo  Resumen

10. Bousquet PJ, Kvedariene V, Co-Minh HB, et al. Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy. 2007 Aug;62(8):872-6. Resumen

11. Plachouri KM, Vryzaki E, Georgiou S. Cutaneous adverse events of immune checkpoint inhibitors: a summarized overview. Curr Drug Saf. 2019;14(1):14-20. Resumen

12. Tan EH, Chan A. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors. Ann Pharmacother. 2009 Oct;43(10):1658-66. Resumen

13. Rosado Ingelmo A, Doña Diaz I, Cabañas Moreno R, et al. Clinical practice guidelines for diagnosis and management of hypersensitivity reactions to contrast media. J Investig Allergol Clin Immunol. 2016;26(3):144-55.Texto completo  Resumen

14. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011 May;71(5):684-700.Texto completo  Resumen

15. Brandt O, Bircher AJ. Delayed-type hypersensitivity to oral and parenteral drugs. J Dtsch Dermatol Ges. 2017 Nov;15(11):1111-32.Texto completo  Resumen

16. Blumenthal KG, Peter JG, Trubiano JA, et al. Antibiotic allergy. Lancet. 2019 Jan 12;393(10167):183-98.Texto completo  Resumen

17. Dodiuk-Gad RP, Chung WH, Valeyrie-Allanore L, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: an update. Am J Clin Dermatol. 2015 Dec;16(6):475-93. Resumen

18. Duong TA, Valeyrie-Allanore L, Wolkenstein P, et al. Severe cutaneous adverse reactions to drugs. Lancet. 2017 Oct 28;390(10106):1996-2011. Resumen

19. Kardaun SH, Sekula P, Valeyrie-Allanore L, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction – results from the prospective RegiSCAR study. Br J Dermatol. 2013 Nov;169(5):1071-80.Texto completo  Resumen

20. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011 Jul;124(7):588-97. Resumen

21. Drago F, Ciccarese G, Gasparini G, et al. Contemporary infectious exanthems: an update. Future Microbiol. 2017 Feb;12:171-93.Texto completo  Resumen

22. Cherry JD. Viral exanthems. Curr Probl Pediatr. 1983 Apr;13(6):1-44. Resumen

23. Renn CN, Straff W, Dorfmuller A, et al. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol. 2002 Dec;147(6):1166-70. Resumen

24. Mancini AJ, Shani-Adir A. Other viral diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1255-320.

25. Celebi G, Pişkin N, Aydemir H, et al. Evaluation of 35 adult measles cases detected in a measles outbreak [in Turkish]. Mikrobiyol Bul. 2007 Jan;41(1):79-86. Resumen

26. Public Health England. National measles guidelines. November 2019 [internet publication].Texto completo

27. Cherry JD. Parvovirus infections in children and adults. Adv Pediatr. 1999;46:245-69. Resumen

28. Kimberlin DW. Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease. Pediatr Infect Dis J. 1998 Jan;17(1):59-67; quiz 68. Resumen

29. Porras B, Costner M, Friedman-Kien AE, et al. Update on cutaneous manifestations of HIV infection. Med Clin North Am. 1998 Sep;82(5):1033-80, v. Resumen

30. Dobson JS, Levell NJ. Spotting Zika spots: descriptive features of the rash used in 66 published cases. Clin Exp Dermatol. 2019 Jan;44(1):4-12.Texto completo  Resumen

31. de Araújo TVB, Rodrigues LC, de Alencar Ximenes RA, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis. 2016 Sep 16;16(12):1356-63.Texto completo  Resumen

32. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis. 2011;204(suppl 3):S810-16.Texto completo  Resumen

33. Dallatomasinas S, Crestani R, Squire JS, et al. Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health. 2015 Apr;20(4):448-54. Resumen

34. WHO Ebola Response Team. Ebola virus disease in West Africa: the first 9 months of the epidemic and forward projections. N Engl J Med. 2014 Oct 16;371(16):1481-95.Texto completo  Resumen

35. Lado M, Walker N, Baker P, et al. Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study. Lancet Infect Dis. 2015 Sep;15(9):1024-33. Resumen

36. Gemmell CG. Staphylococcal scalded skin syndrome. J Med Microbiol. 1995 Nov;43(5):318-27. Resumen

37. Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J Am Acad Dermatol. 1994 Feb;30(2 Pt 2):319-24. Resumen

38. Hajjeh RA, Reingold A, Weil A, et al. Toxic shock syndrome in the United States: surveillance update, 1979-1996. Emerg Infect Dis. 1999 Nov-Dec;5(6):807-10.Texto completo  Resumen

39. Reingold AL, Hargrett NT, Shands KN, et al. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med. 1982 Jun;96(6 Pt 2):875-80. Resumen

40. UK Health Security Agency. Scarlet fever: symptoms, diagnosis and treatment. Mar 2019 [internet publication].Texto completo

41. UK Health Security Agency. Group A streptococcal infections: report on seasonal activity in England, 2022 to 2023. Dec 2022 [internet publication].Texto completo

42. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012 Nov 15;55(10):e86-102.Texto completo  Resumen

43. Committee on Infectious Diseases; American Academy of Pediatrics. Red book. 32nd ed. Elk Grove Village, IL: AAP; 2021.

44. Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009 Mar 24;119(11):1541-51.Texto completo  Resumen

45. Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, et al. Current perspectives on erythema multiforme. Clin Rev Allergy Immunol. 2018 Feb;54(1):177-84. Resumen

46. Buckingham SC, Marshall GS, Schutze GE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr. 2007 Feb;150(2):180-4. Resumen

47. Zeiser R, Blazar BR. Acute graft-versus-host disease: biologic process, prevention, and therapy. N Engl J Med. 2017 Nov 30;377(22):2167-79.Texto completo  Resumen

48. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017 Apr 25;135(17):e927-99.Texto completo  Resumen

49. National Institute for Health and Care Excellence. Fever in under 5s: assessment and initial management. Nov 2021 [internet publication].Texto completo

50. Mehrpoor G, Owlia MB, Soleimani H, et al. Adult-onset Still's disease: a report of 28 cases and review of the literature. Mod Rheumatol. 2008;18(5):480-5. Resumen

51. Falcini F, Cimaz R. Juvenile rheumatoid arthritis. Curr Opin Rheumatol. 2000 Sep;12(5):415-9. Resumen

52. Vanden Hoek TL, Morrison LJ, Shuster M, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010 Nov 2;122(18 suppl 3):S829-61.Texto completo  Resumen

53. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.Texto completo  Resumen

54. National Institute for Health and Care Excellence. Sepsis: recognition, diagnosis and early management. September 2017 [internet publication].Texto completo

55. Royal College of Physicians. National early warning score (NEWS) 2: standardising the assessment of acute-illness severity in the NHS. December 2017 [internet publication].Texto completo

56. American College of Emergency Physicians (ACEP) Expert Panel on Sepsis. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. 2016 [internet publication].Texto completo

57. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Texto completo  Resumen

58. Surviving Sepsis Campaign. Hour-1 bundle: initial resuscitation for sepsis and septic shock. 2019 [internet publication].Texto completo

59. Gottlieb M, Long B, Koyfman A. The evaluation and management of Rocky Mountain spotted fever in the emergency department: a review of the literature. J Emerg Med. 2018 Jul;55(1):42-50. Resumen

60. Nkoghe D, Leroy EM, Toung-Mve M, et al. Cutaneous manifestations of filovirus infections. Int J Dermatol. 2012 Sep;51(9):1037-43. Resumen

61. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. 2009 [internet publication].Texto completo  Resumen

62. World Health Organization. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever. 2011 [internet publication].Texto completo

63. World Health Organization. Handbook for clinical management of dengue. 2012 [internet publication].Texto completo

64. Ely JW, Seabury Stone M. The generalized rash: part II. Diagnostic approach. Am Fam Physician. 2010 Mar 15;81(6):735-9.Texto completo  Resumen

65. Belum VR, Benhuri B, Postow MA, et al. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor. Eur J Cancer. 2016 Jun;60:12-25.Texto completo  Resumen

66. Berbis, P. Rickettsial diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1165-70.

67. O'Byrne P, MacPherson P. Syphilis. BMJ. 2019 Jun 28;365:l4159.Texto completo  Resumen

68. Stary A. Sexually transmitted diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1271-81.

69. Blume JE, Levine EG, Heymann WR. Bacterial diseases. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. Elsevier; 2003:1117-44.

70. Evans AS, Niederman JC, Cenabre LC, et al. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1999 Nov-Dec;5(6):807-10. Resumen

71. Ferry T, Thomas D, Bouchut JC, et al. Early diagnosis of staphylococcal toxic shock syndrome by detection of the TSST-1 Vbeta signature in peripheral blood of a 12-year-old boy. Pediatr Infect Dis J. 2008 Mar;27(3):274-7. Resumen

72. Mirakian R, Ewan PW, Durham SR, et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009 Jan;39(1):43-61.Texto completo  Resumen

73. Nigen S, Knowles SR, Shear NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol. 2003 Jun;2(3):278-99. Resumen

74. Hassoun-Kheir N, Bergman R1, Weltfriend S. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions. Int J Dermatol. 2016 Nov;55(11):1219-24. Resumen

75. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general consideration. Allergy. 2003 Sep;58(9):854-63. Resumen

76. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol. 2005 May;152(5):968-74. Resumen

77. Elzagallaai AA, Knowles SR, Rieder MJ, et al. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32(5):391-408. Resumen

78. Cham PM, Warshaw EM. Patch testing for evaluating drug reactions due to systemic antibiotics. Dermatitis. 2007 Jun;18(2):63-77. Resumen

79. Lammintausta K, Kortekangas-Savolainen O. Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol. 2005;85(6):491-6. Resumen

80. Centers for Disease Control and Prevention. Collecting and shipping specimens for suspected measles cases. November 2020 [internet publication].Texto completo

81. Windfuhr JP, Toepfner N, Steffen G, et al. Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management. Eur Arch Otorhinolaryngol. 2016 Apr;273(4):973-87.Texto completo  Resumen

82. Cohen JF, Bertille N, Cohen R, et al. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016 Jul 4;7(7):CD010502.Texto completo  Resumen

83. Lean WL, Arnup S, Danchin M, et al. Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis. Pediatrics. 2014 Oct;134(4):771-81. Resumen

84. Barakat AJ, Evans C, Gill M, et al. Rapid strep testing in children with recently treated streptococcal pharyngitis. Pediatr Investig. 2019 Mar;3(1):27-30.Texto completo  Resumen

85. Biggs HM, Behravesh CB, Bradley KK, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis: United States. MMWR Recomm Rep. 2016 May 13;65(2):1-44.Texto completo  Resumen

86. Centers for Disease Control and Prevention. Chikungunya virus: diagnostic testing. December 2018 [internet publication].Texto completo

87. Sharp TM, Fischer M, Muñoz-Jordán JL, et al. Dengue and Zika virus diagnostic testing for patients with a clinically compatible illness and risk for infection with both viruses. MMWR Recomm Rep. 2019 Jun 14;68(1):1-10.Texto completo  Resumen

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad